[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356739-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-356739-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","a-multidimensional-nomogram-integrating-immune-inflammatory-and-coagulation-markers-for-personalized-prognosis-in-bladder-cancer","A multidimensional nomogram integrating immune, inflammatory, and coagulation markers for personalized prognosis in bladder cancer","","Objective: Develop and validate an integrated prognostic model using tumor immune microenvironmental, systemic inflammatory, and coagulation markers to improve prognostic stratification and personalize management for bladder cancer patients undergoing surgery. Methods: A retrospective cohort of 140 patients treated with radical or partial cystectomy (2013-2021) was analyzed; cutoff values were determined by ROC analysis and prognostic factors by univariate/multivariate Cox regression. A nomogram was then built and validated.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/a-multidimensional-nomogram-integrating-immune-inflammatory-and-coagulation-markers-for-personalized-prognosis-in-bladder-cancer/356739/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/a-multidimensional-nomogram-integrating-immune-inflammatory-and-coagulation-markers-for-personalized-prognosis-in-bladder-cancer/356739.png","ImageObject",300,407,{"name":42,"@type":43},"นรินทร์","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main goal of the proposed nomogram for bladder cancer?","Question",{"text":63,"@type":64},"To integrate immune, inflammatory, and coagulation markers into a single prognostic tool that improves risk stratification and supports personalized postoperative management.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were prognostic factors and cutoff values determined in the study?",{"text":68,"@type":64},"Continuous variable cutoffs were selected using receiver operating characteristic (ROC) analysis, and independent prognostic factors for overall survival were identified using univariate and multivariate Cox regression.",{"name":70,"@type":61,"acceptedAnswer":71},"Which variables were identified as independent predictors of overall survival?",{"text":72,"@type":64},"Tertiary lymphoid structure density, hemoglobin level, D-dimer level, platelet-to-lymphocyte ratio, and clinical stage.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356739,1790930703,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336475104957,"https://ap-avatar.wpscdn.com/avatar/22000c4c6bd8a5076e1?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787554080175789136","A multidimensional nomogram integrating immune, inflammatory, and coagulation markers for personalized prognosis in bladder cancer  \nYongpeng Li 1,2,*, Wei Wei 1,2,3,*, Chanzhen Liu 1,2,3 , Haoyuan Lu2,3,4,5, Rongchao Chen6, Shengming Wu 1,  \nYouzhi Lin 1,3, Huadong Xie7, Chengjie Ban8, Xianlin Yi9 and Yong Tang 1,2,3,4,5  \nJournal of International Medical Research 2026, Vol. 54(4) 1–22! The Author(s) 2026 Article reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/03000605261441388](DOI: 10.1177/03000605261441388)[ ](DOI: 10.1177/03000605261441388)[journals.sagepub.com/home/imr](journals.sagepub.com/home/imr)  \nAbstract  \nObjective: To develop and validate an integrated prognostic model based on tumor immune microenvironmental, systemic inflammatory, and coagulation markers to improve prognostic stratification and personalize management for bladder cancer patients undergoing surgery. Methods: This retrospective study analyzed 140 patients who underwent radical or partial cystectomy at our institution between 2013 and 2021 . Cutoff values for continuous variables were determined using receiver operating characteristic analysis. Independent prognostic factors for overall survival were identified using univariate and multivariate Cox regression analyses.  \n1 Guangxi Medical University Cancer Hospital, China 2Guangxi Clinical Research Center for Bladder Cancer, China  \n3University Engineering Research Center of Oncolytic & Nanosystem Development, China  \n4Department of Urology, Guangxi Medical University Cancer Hospital, China  \n5Guangxi Key Laboratory of Extremely Weak Magnetic Field in Cancer Medicine, China  \n6Department of Urology, Red Cross Hospital of Yulin City, China  \n7Department of Urology, The Fourth Affiliated Hospital of Guangxi Medical University, China  \n8Department of Urology, The First Affiliated Hospital of Guangxi University of Chinese Medicine, China 9Maternal and Child Health Hospital of Hubei province, Tongji Medical College, Huazhong University of Science and Technology China  \n*These authors contributed equally to this work.  \nCorresponding authors:  \nYong Tang, Guangxi Medical University Cancer Hospital, 50 Liang Yu Avenue, Nanning, Guangxi 530221, China.  \nEmail: [yong_tang_md@hotmail.com](yong_tang_md@hotmail.com)  \nXianlin Yi, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei China.  \nEmail: [yixianlin@gxmu.edu.cn](yixianlin@gxmu.edu.cn)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative  \nCommons Attribution-NonCommercial 4.0 License ([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages ([https://us.sagepub.com/en-us/nam/open-access-at-sage](https://us.sagepub.com/en-us/nam/open-access-at-sage)).  \nA nomogram was subsequently developed and validated using time-dependent receiver operating characteristic curves, calibration plots, and decision curve analysis.  \nResults: Multivariate analysis confirmed that tertiary lymphoid structure density, hemoglobin level, D-dimer level, platelet-to-lymphocyte ratio, and clinical stage are independent predictors of overall survival. The constructed nomogram demonstrated high predictive accuracy for 1-, 3-, and 5-year overall survivals, with area under the curve values of 0.868, 0.880, and 0.894, respectively. Calibration and decision curve analyses confirmed the model’s excellent consistency and clinical utility. Risk stratification based on the nomogram revealed significant survival differences between the groups (p \u003C0.001).  \nConclusion: We developed and validated a novel nomogram that integrates multidimensional immune microenvironmental, systemic inflamma","cbCaiu0ZtuP5FKuZ","https://ap.wps.com/l/cbCaiu0ZtuP5FKuZ","pdf",1553036,22,"English","# Abstract\n## Objective\n## Methods\n## Results\n## Conclusion\n# Keywords\n# Introduction","[{\"question\":\"What is the main goal of the proposed nomogram for bladder cancer?\",\"answer\":\"To integrate immune, inflammatory, and coagulation markers into a single prognostic tool that improves risk stratification and supports personalized postoperative management.\"},{\"question\":\"How were prognostic factors and cutoff values determined in the study?\",\"answer\":\"Continuous variable cutoffs were selected using receiver operating characteristic (ROC) analysis, and independent prognostic factors for overall survival were identified using univariate and multivariate Cox regression.\"},{\"question\":\"Which variables were identified as independent predictors of overall survival?\",\"answer\":\"Tertiary lymphoid structure density, hemoglobin level, D-dimer level, platelet-to-lymphocyte ratio, and clinical stage.\"}]","A multidimensional nomogram integrating immune, inflammatory, and coagulation markers for personalized prognosis in bladder cancer | PDF",1790127028,55,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b65ca620eaee9b732711283749053741.webp",983,1399,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a8e7ddb3bf5a0b035e50859adff5633e.webp",982,1398,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dfedf0bf652b4c09f076ba1b203ce267.webp",981,1396,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0c6565b926dfbae6755156ba462bd3a4.webp",980,1395]